At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer
In Brief
An observational study for Breast Cancer. Completed, enrolled 65 participants across 1 site.
Detailed Summary
This is a prospective observational study designed to determine the feasibility and acceptability of objectively measuring physical activity, sedentary time, and sleep using the Fitbit Charge HR wristband. 50 patients who have been diagnosed with breast cancer and are planning to initiate chemotherapy will be invited to participate in this study, and we will measure general and breast-specific quality-of-life using Patient-Reported Outcomes Measurement Information System (PROMIS) measures for 3-6 months after completion of chemotherapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedFeb 2017
Primary CompletionJan 2018
Study CompletionDec 2018
TodayJul 2026
First PostedFeb 7, 2017
Enrollment StartAug 2, 2016
Primary CompletionJan 18, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.4 years ago